•  
  •  
 

Volume 15, Issue 3 (2022)

Review Articles

PDF

Management of CAR T-cell related toxicities: What did the learning curve teach us so far?
Hemant S. Murthy, Farah Yassine, Madiha Iqbal, Shaikha Alotaibi, Mohamad A. Moustafa, and Mohamed A. Kharfan-Dabaja

PDF

Chimeric antigen receptor structure and manufacturing of clinical grade CAR engineered cells using different bioreactors
Farhatullah Syed, Riad El Fakih, Ali Debsan Alahmari, Ahmed Syed Osman Ali, and Mahmoud Aljurf

PDF

Understanding the etiology of pancytopenias in the CAR T-cell therapy setting: what we know and what we don’t?
Farah Yassine, Hemant Murthy, Emad Ghabashi, Mohamed A. Kharfan-Dabaja, and Madiha Iqbal

PDF

Infectious complications and preventative strategies following Chimeric Antigen Receptor T-cells (CAR-T cells) therapy for B-cell malignancies
Alfadil Haroon, Ibrahim N. Muhsen, Muhammad Bilal Abid, Abdulwahab Albabtain, Ali Alahmari, Syed Osman Ahmed, Riad El Fakih, and Mahmoud Aljurf

PDF

Chimeric Antigen Receptor T-cell Therapy for Acute Myeloid Leukemia
Xia Bi, Jingmei Hsu, Mia Gergis, Yang Yang, Dongni Yi, and Usama Gergis

PDF

Chimeric Antigen Receptor T-Cell Therapies in Lymphoma Patients with Central Nervous System Involvement
Dongni Yi, Mia Gergis, Ghada Elgohary, Jingmei Hsu, Yang Yang, Xia Bi, and Usama Gergis

PDF

CAR-T cell Therapies for B-cell Lymphoid Malignancies: Identifying Targets Beyond CD19
Yenny M. Vanegas, Razan Mohty, Martha E. Gadd, Yan Luo, Mahmoud Aljurf, Hong Qin, and Mohamed A. Kharfan-Dabaja

PDF

Chimeric antigen receptor T cell therapy for solid tumors
Jingmei Hsu, Yang Yang, Mia Gergis, Xia Bi, Dongni Yi, and Usama Gergis

PDF

Allogeneic Chimeric Antigen Receptor T Cells for Hematologic Malignancies
Yang Yang, Xia Bi, Mia Gergis, Dongni Yi, Jingmei Hsu, and Usama Gergis

PDF

Adoptive cellular therapy in acute myeloid leukemia: Current scope and challenges
Sankalp Arora, Palash Asawa, Aravind Ramakrishnan, Carlos Bachier, and Navneet S Majhail

PDF

Emerging role of autologous CD19 CAR T-cell therapies in the second-line setting for large B-cell lymphoma: A game changer?
Razan Mohty, Muhamad A. Moustafa, Mahmoud Aljurf, Hemant Murthy, and Mohamed A. Kharfan-Dabaja

Original Research Report

PDF

Next-Generation Chimeric Antigen Receptor T Cells
Dongni Yi, Mia Gergis, Jingmei Hsu, Yang Yang, Xia Bi, Mahmoud Aljurf, and Usama Gergis